EHTH · eHealth, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA margin non-GAAP | 10% | Q1 2026 | — |
|
|
|||
| Medicare Advantage constrained LTV of commissions | 3% | Q1 2026 | — |
| Medicare LTV-to-CAC ratio non-GAAP | 1.4 | Q1 2026 | — |
|
|
|||
| Medicare Part D constrained LTV of commissions | 78% | Q1 2026 | — |
| Medicare segment gross margin | 41% | Q1 2026 | — |
| Medicare Supplement constrained LTV of commissions | 19% | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | $97.3M | FY 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance Brokers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EHTH
this stock
eHealth, Inc.
|
$41.90M | -71.3% | +17.6% | — | 2.4% |
|
MRSH
Marsh & Mclennan Companies, Inc.
|
$94.29B | +7.0% | +9.7% | 24.2 | 1.4% |
|
AON
Aon plc
|
$80.55B | +6.9% | -0.7% | 20.7 | 2.1% |
|
AJG
Arthur J. Gallagher & Co.
|
$69.08B | +4.2% | +16.6% | 43.5 | 3.1% |
|
WTW
Willis Towers Watson PLC
|
$29.84B | -3.5% | -2.2% | 18.6 | 3.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EHTH | -6.4% | -11.4% | -48.4% | -11.4% | -71.3% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -4.0% | -9.1% | -54.8% | -9.1% | -78.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.